HIVE Digital Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

HIVE Digital Technologies wird ein Gewinn- und Umsatzwachstum von 78.9% bzw. 46.4% pro Jahr prognostiziert, während der Gewinn pro Aktie um 84.8% pro Jahr wachsen soll.

Wichtige Informationen

94.3%

Wachstumsrate der Gewinne

99.8%

EPS-Wachstumsrate

Software Gewinnwachstum	27.3%
Wachstumsrate der Einnahmen	48.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	19 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 27% Dip In Price Shows Sentiment Is Matching Revenues

Aug 15

A Piece Of The Puzzle Missing From HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Climb

Jun 13

Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Jun 06

Slammed 25% HIVE Digital Technologies Ltd. (CVE:HIVE) Screens Well Here But There Might Be A Catch

Mar 23

Market Cool On HIVE Digital Technologies Ltd.'s (CVE:HIVE) Revenues Pushing Shares 28% Lower

Feb 03

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 25% Jump Shows Its Popularity With Investors

Dec 20

Under The Bonnet, HIVE Blockchain Technologies' (CVE:HIVE) Returns Look Impressive

Jul 19

Is Now The Time To Put HIVE Blockchain Technologies (CVE:HIVE) On Your Watchlist?

Jun 12

HIVE Blockchain Technologies Ltd.'s (CVE:HIVE) 30% Dip In Price Shows Sentiment Is Matching Earnings

Apr 28

HIVE Blockchain Technologies (CVE:HIVE) Could Become A Multi-Bagger

Mar 30

Do HIVE Blockchain Technologies's (CVE:HIVE) Earnings Warrant Your Attention?

Mar 09

Here's Why HIVE Blockchain Technologies (CVE:HIVE) Can Manage Its Debt Responsibly

Feb 16

Investors Should Be Encouraged By HIVE Blockchain Technologies' (CVE:HIVE) Returns On Capital

Nov 03

HIVE Blockchain Technologies (CVE:HIVE) Has A Pretty Healthy Balance Sheet

Sep 28

Here's Why We Don't Think HIVE Blockchain Technologies's (CVE:HIVE) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 20

Gewinn- und Umsatzwachstumsprognosen

TSXV:HIVE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	555	119	N/A	N/A	1
3/31/2026	228	4	N/A	N/A	2
3/31/2025	118	-28	N/A	N/A	4
6/30/2024	123	-32	-84	-6	N/A
3/31/2024	114	-51	-66	14	N/A
12/31/2023	96	-41	-36	31	N/A
9/30/2023	79	-128	-24	31	N/A
6/30/2023	86	-137	1	46	N/A
3/31/2023	106	-236	2	45	N/A
12/31/2022	138	-277	-49	61	N/A
9/30/2022	192	-132	-72	78	N/A
6/30/2022	216	-60	-126	76	N/A
3/31/2022	211	80	-147	66	N/A
12/31/2021	196	109	-132	57	N/A
9/30/2021	141	76	-99	41	N/A
6/30/2021	100	46	-59	29	N/A
3/31/2021	68	24	-42	24	N/A
12/31/2020	39	29	-2	21	N/A
9/30/2020	30	15	1	5	N/A
6/30/2020	27	-5	-4	0	N/A
3/31/2020	29	-2	-1	1	N/A
12/31/2019	30	-73	-1	-1	N/A
9/30/2019	34	-113	-5	-5	N/A
6/30/2019	30	-130	-9	-9	N/A
3/31/2019	32	-138	-2	-2	N/A
12/31/2018	35	-74	-87	-19	N/A
9/30/2018	30	-37	-123	-19	N/A
6/30/2018	24	-28	-129	-16	N/A
3/31/2018	13	-26	N/A	-25	N/A
12/31/2017	3	-20	N/A	-7	N/A
9/30/2017	0	-20	N/A	-1	N/A
6/30/2017	N/A	0	N/A	-2	N/A
3/31/2017	N/A	-1	N/A	0	N/A
12/31/2016	N/A	-1	N/A	-1	N/A
9/30/2016	N/A	-1	N/A	-1	N/A
6/30/2016	N/A	-1	N/A	0	N/A
3/31/2016	N/A	-1	N/A	0	N/A
12/31/2015	N/A	-1	N/A	0	N/A
9/30/2015	N/A	-1	N/A	0	N/A
6/30/2015	N/A	-1	N/A	0	N/A
3/31/2015	N/A	-1	N/A	0	N/A
12/31/2014	N/A	-1	N/A	0	N/A
9/30/2014	N/A	-1	N/A	0	N/A
6/30/2014	N/A	-1	N/A	0	N/A
3/31/2014	N/A	-1	N/A	0	N/A
12/31/2013	N/A	-1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: HIVE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.1%).

Ertrag vs. Markt: HIVE wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: HIVE wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: HIVEDie Einnahmen des Unternehmens (46.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (7.3% pro Jahr).

Hohe Wachstumseinnahmen: HIVEDie Einnahmen des Unternehmens (46.4% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von HIVE in 3 Jahren voraussichtlich hoch sein wird

HIVE Digital Technologies Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus forecasts updated

Price target increased to CA$4.38

Recent updates

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 27% Dip In Price Shows Sentiment Is Matching Revenues

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

HIVE Digital Technologies Ltd. to Report Q1, 2025 Results on Aug 13, 2024

New minor risk - Share price stability

Full year 2024 earnings: EPS and revenues exceed analyst expectations

HIVE Digital Technologies Ltd. to Report Fiscal Year 2024 Results on Jun 24, 2024

A Piece Of The Puzzle Missing From HIVE Digital Technologies Ltd.'s (CVE:HIVE) 28% Share Price Climb

Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

Slammed 25% HIVE Digital Technologies Ltd. (CVE:HIVE) Screens Well Here But There Might Be A Catch

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Market Cool On HIVE Digital Technologies Ltd.'s (CVE:HIVE) Revenues Pushing Shares 28% Lower

Independent Director recently sold CA$52k worth of stock

Independent Director exercised options to buy CA$872k worth of stock.

HIVE Digital Technologies Ltd.'s (CVE:HIVE) 25% Jump Shows Its Popularity With Investors

New major risk - Financial position

Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?

HIVE Digital Technologies Ltd., Annual General Meeting, Oct 17, 2023

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Revenue and earnings growth

Full year 2023 earnings: EPS exceeds analyst expectations

Is HIVE Blockchain Technologies (CVE:HIVE) A Risky Investment?

Independent Director recently sold CA$53k worth of stock

Independent Director recently sold CA$69k worth of stock

Independent Director recently sold CA$55k worth of stock

HIVE Blockchain Technologies (CVE:HIVE) Is Making Moderate Use Of Debt

Third quarter 2023 earnings: EPS misses analyst expectations

Hive Blockchain Technologies Ltd. Appoints Aydin Kilic as Chief Executive Officer

HIVE Blockchain Technologies Ltd. Reports Impairment Results for the Quarter Ended September 30, 2022

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

HIVE Blockchain Technologies Ltd., Annual General Meeting, Dec 20, 2022

Independent Director recently sold CA$75k worth of stock

HIVE Blockchain Technologies Ltd. Appoints Mr. Gabriel Ibghy as General Counsel

Investor sentiment improved over the past week

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

HIVE Blockchain Technologies Ltd. Reports Impairment of Goodwill and Intangibles for the Fourth Quarter Ended March 31, 2022

Investor sentiment improved over the past week

Under The Bonnet, HIVE Blockchain Technologies' (CVE:HIVE) Returns Look Impressive

HIVE Blockchain Technologies Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Form 40 F

HIVE Blockchain Technologies Ltd. to Report Fiscal Year 2022 Results on Jul 15, 2022

Is Now The Time To Put HIVE Blockchain Technologies (CVE:HIVE) On Your Watchlist?

Investor sentiment improved over the past week

Consensus forecasts updated

Investor sentiment deteriorated over the past week

HIVE Blockchain Technologies Ltd.'s (CVE:HIVE) 30% Dip In Price Shows Sentiment Is Matching Earnings

Price target increased to CA$4.38

HIVE Blockchain Technologies (CVE:HIVE) Could Become A Multi-Bagger

Investor sentiment improved over the past week

Do HIVE Blockchain Technologies's (CVE:HIVE) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Here's Why HIVE Blockchain Technologies (CVE:HIVE) Can Manage Its Debt Responsibly

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

HIVE Blockchain Technologies Ltd. to Report Q3, 2022 Results on Feb 15, 2022

Investor sentiment improved over the past week

Independent Director recently bought CA$128k worth of stock

Investor sentiment deteriorated over the past week

Chief Financial Officer recently sold CA$54k worth of stock

Chief Financial Officer recently sold CA$54k worth of stock

Investor sentiment improved over the past week

Independent Director recently bought CA$92k worth of stock

Investor sentiment deteriorated over the past week

HIVE Blockchain Technologies Ltd. announced that it has received CAD 115.023 million in funding

Chief Financial Officer recently sold CA$74k worth of stock

Independent Director recently sold CA$318k worth of stock

Second quarter 2022 earnings released: EPS US$0.16 (vs US$0.027 in 2Q 2021)

Investor sentiment improved over the past week

Investors Should Be Encouraged By HIVE Blockchain Technologies' (CVE:HIVE) Returns On Capital

Independent Director recently sold CA$881k worth of stock

Investor sentiment improved over the past week

HIVE Blockchain Technologies (CVE:HIVE) Has A Pretty Healthy Balance Sheet

Full year 2021 earnings released: EPS US$0.12 (vs US$0.005 loss in FY 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week